| Ytd | -42.37% | |
| 1y | -90.21% |
| Open | 3.60 | Prev Close | 3.43 | Low | 3.21 | High | 3.60 | Mkt Cap | 6.17M |
| Vol | 43.46K | Avg Vol | 143.23K | EPS | -16.62 | P/E | N/A | Forward P/E | -0.73 |
| Beta | 2.32 | Short Ratio | 0.28 | Inst. Own | 3.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.81 | 200-d Avg | 6.09 | 1yr Est | 3.00 |
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a U.S.-based c
Human studies show that the TGF-β trap and IL-15 fusion used alone promotes expansion of progenitor
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's aft
MIRAMAR, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics
On August 10, 2026, the Audit Committee of the Board of Directors (the "Audit Committee") of
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-sta
MIRAMAR, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a U.S.-based c
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strateg
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
HCW Biologics Inc. (the "Company" or "HCW Biologics") (Nasdaq: HCWB), a U.S.-based c
MIRAMAR, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based cl
Company completed 28 consecutive trading days above $1.00 per share on June 25, 2026 Reverse stock s
HCW Biologics Inc. (NASDAQ:HCWB) stock fell during Tuesday's session. The company announced prelimin
HCW Biologics reports positive Phase 1 data for HCW9302, with all 2nd-cohort alopecia patients showi
Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating r
Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating r
https://www.sec.gov/Archives/edgar/data/1828673/000149315226027656/forms-1.htm
Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raise
HCW Biologics Inc. (the "Company") (NASDAQ:HCWB), a clinical-stage biopharmaceutical company
Positions the Company to participate in fast-growing, multi-billion-dollar CAR-T immunotherapy marke
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking
HCW Biologics Inc. (NASDAQ: HCWB) stock rallies on Friday as a $4 million private placement offering
HCW Biologics Inc. (NASDAQ:HCWB) stock is rallying after securing a $4 million private placement to
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-sta
MIRAMAR, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”
HCW Biologics Inc. (NASDAQ: HCWB) stock falls on Tuesday. Retail traders lock in gains after a 262%
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
HCW Biologics (HCWB) reports Q1 EPS of $0.37 and $6.54M in sales. Find out why the stock skyrocketed
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $
HCW Biologics shares soared Friday after the company reported stronger quarterly results, advanced a
US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; mate
Dow Jones falls 500 points, S&P drops 1.29%, NASDAQ down 1.79%. Energy shares rise 1.2%, tech st
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings
HCW Biologics Inc. surged 122.55% in after-hours trading after reporting first-quarter EPS that shar
HCW Biologics Inc. surged 122.55% in after-hours trading after reporting first-quarter EPS that shar
HCW Biologics (NASDAQ:HCWB) reported quarterly earnings of $0.37 per share which beat the analyst co
MIRAMAR, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a U.S.-based c